Assembly and publication of the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) genome in January 2020 enabled the immediate development of tests to detect the …

Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …

The development of vaccines against SARS-CoV-2 would be greatly facilitated by the
identification of immunological correlates of protection in humans. However, to date, studies …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
global pandemic in 2020. Testing is crucial for mitigating public health and economic effects …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated
coronavirus disease 2019 (COVID-19) pandemic has demanded rapid upscaling of in-vitro …

Abstract Background Coronavirus disease 2019 (COVID-19) and dengue fever are difficult
to distinguish given shared clinical and laboratory features. Failing to consider COVID-19 …

Background The emergence of new SARS-CoV-2 has promoted the development of new
serological tests that could be complementary to RT-PCR. Nevertheless, the assessment of …

The role of serologic testing for severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), in both the clinical and public health settings, will continue to evolve as we gain …

ABSTRACT The Elecsys Anti-SARS-CoV-2 immunoassay (Roche Diagnostics) was
developed to provide accurate, reliable detection of antibodies to severe acute respiratory …

Accurate serologic tests to detect host antibodies to severe acute respiratory syndrome–
related coronavirus 2 (SARS-CoV-2) will be critical for the public health response to the …